PMC/PubMed Indexed Articles
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Publons
- International committee of medical journals editors (ICMJE)
- Geneva Foundation for Medical Education and Research
Useful Links
Share This Page
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Outcomes in patients with first episode schizophrenia treated with long-acting antipsychotic injections
27th International Conference on PSYCHIATRY & PSYCHOLOGY HEALTH
June 18-19, 2018 Paris, France
A Vishal and Nagapadma Medi
Nizamabad Medical College, India
Indur Neuro Psychiatric Hospital, India
Scientific Tracks Abstracts: J Psychiatry
Abstract:
Background: Noncompliance is a major problem for patients with first episode schizophrenia. Long-acting injectable antipsychotics (LAI APs) should offer better efficacy and tolerability compared to oral antipsychotics due to improved adherence and more stable pharmacokinetics. LAI APs have proved the effectiveness in first episode schizophrenia because they assure stable blood levels leading to a reduction of the risk of relapse. Objectives: The objective is to compare the clinical efficacy of the long-acting injectable antipsychotics with the oral antipsychotics in the first episode of schizophrenia. Methods: Parameters were assessed at baseline and at 3 month intervals for 2 years in patients initiated on long-acting injection (LAI) (n=673) or a new oral antipsychotics (AP) (n=139 on risperidone and olanzapine) at Nizamabad. Hospitalization prior to therapy was assessed by a retrospective chart review. Results: At two years treatment retention and reduction in Clinical Global Impression Severity, scores were significantly higher with LAI. Compared to the pre-switch period, LAI Aps patients had greater reductions in the number of hospitalizations at two years than oral AP patients. Conclusions: This study showed that, compared to oral antipsychotics, LAI APs were associated with better treatment retention, greater improvement in clinical symptoms and functioning and greater reduction in hospital stays and days at hospital in patients with first episode schizophrenia.
Biography :
A Vishal has completed his MD in Psychiatry from NTR University of Health Sciences, Vijayawada. Now, he is working as Assistant Professor of Psychiatry at Government Medical College, Nizamabad, Telangana, India.
E-mail: drvishalakula@gmail.com